Join the movement to end censorship by Big Tech. StopBitBurning.com needs donations and support.
Hep B vaccine for newborns: A dangerous mandate, a needless vaccine, driven by profit, not science
By ljdevon // 2025-05-14
Mastodon
    Parler
     Gab
 Copy
 
Every newborn in America is injected with the hepatitis B (Hep B) vaccine within hours of birth—despite the fact that the disease is primarily transmitted through unprotected sex and intravenous drug use. Why is the CDC pushing a vaccine meant for high-risk adults onto infants who face virtually no exposure? The answer lies in a web of corporate influence, skewed data, and a liability shield that protects pharmaceutical giants while putting babies at risk. The CDC claims that up to 320,000 new Hep B infections occur annually, yet only about 10,000 cases are actually reported. Meanwhile, adverse reactions—from autoimmune disorders to neurological damage—are downplayed or ignored. With billions in profits at stake, the push to vaccinate every child appears less about public health and more about padding the pockets of Merck and GSK. Key points:
  • The CDC recommends the Hep B vaccine for all newborns, despite the disease being nearly impossible for infants to contract outside of rare maternal transmission.
  • Clinical trials for the vaccine were minimal, with safety monitoring lasting only 4-5 days—no long-term studies were conducted.
  • Adverse reactions include autoimmune disorders, neurological damage, and developmental delays, yet vaccine manufacturers face no liability.
  • The mandate was expanded after the 1986 National Childhood Vaccine Injury Act shielded drug companies from lawsuits.
  • A growing number of doctors and scientists argue the vaccine provides no benefit to most children while exposing them to unnecessary risks.

A questionable mandate with no scientific basis

Hepatitis B is a liver disease transmitted through blood and bodily fluids—primarily via unprotected sex, needle sharing, or from an infected mother during childbirth. The CDC admits that "almost all children and older adults infected with acute HBV recover completely with no lasting liver damage." So why vaccinate every baby at birth? Before 1991, the CDC only recommended the vaccine for high-risk groups, such as healthcare workers, IV drug users, and infants born to Hep B-positive mothers. But after the National Vaccine Injury Compensation Program (VICP) was established in 1988—protecting manufacturers from lawsuits—the CDC suddenly expanded the recommendation to all infants. Attorney Aaron Siri, who obtained CDC records through a Freedom of Information Act request, found no evidence that Hep B has ever been transmitted in a school setting. "The Hepatitis B vaccine is a case study in agency capture," Siri wrote. "All children would not be required to take the shot if pharma didn’t stand to earn billions."

Dangers hidden in the fine print

The two Hep B vaccines given to newborns—Merck’s Recombivax HB and GSK’s Engerix-B—were tested in small, short-term trials with minimal safety oversight. The Recombivax trials involved only 147 infants, monitored for just five days after each dose. Despite this, adverse reactions—including fever, diarrhea, and respiratory infections—were reported in 10% of infants. Post-marketing data reveals far more severe risks:
  • Autoimmune disorders (lupus, multiple sclerosis)
  • Neurological damage (Guillain-Barré syndrome, encephalitis)
  • Developmental delays (autism linked in some studies)
  • Sleep apnea in premature infants
Heather Ray of Children’s Health Defense highlights another alarming fact: Newborns receive the same dose as adults, exposing their tiny bodies to neurotoxic aluminum adjuvants. "Aluminum is a heavy metal that can cross the blood-brain barrier," Ray warns. "It has been scientifically shown to cause autism, asthma, and autoimmune diseases." It's also found in patients with Alzheimer's.

A profit-driven scheme with no real benefit

For most infants, the Hep B vaccine offers zero benefit—only risk. As policy analyst Catherine Pakaluk notes, the vaccine "provides a robust antibody response to a disease to which they are not regularly exposed." In other words, it’s a solution in search of a problem. J.B. Handley, a vocal critic of the mandate, puts it bluntly: "It’s a nearly useless vaccine, unless you are in the tiny minority of babies who have a mother with Hepatitis B." Despite petitions demanding proper safety trials, the CDC and FDA refuse to revisit the mandate. Parents often have to step in after a hospital birth and tell the pediatrician "NO" to protect their vulnerable new infant from this needless vaccine. The Hep B vaccine mandate is not about protecting children—it’s about protecting profits. With the Hep B vaccine market projected to hit $13 billion by 2032, the financial incentive to keep pushing the shot is clear. With no real benefit for the vast majority of infants and a growing list of potential harms, parents deserve the right to question and refuse this unnecessary medical intervention. Until independent, long-term safety studies are conducted, injecting newborns with this vaccine remains a dangerous gamble—one that hospital administrators and pediatricians are all too willing to take. Sources include: ChildrensHealthDefense.org FDA.gov Enoch, Brighteon.ai
Mastodon
    Parler
     Gab
Copy